ÌìÃÀ´«Ã½

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
ÌìÃÀ´«Ã½ Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ÌìÃÀ´«Ã½ Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 4334

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • ÌìÃÀ´«Ã½ J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Development and progression of Alzheimer′s disease in Sprague-Dawley rats administered with streptozotocin intrahippocampally

11th International Conference on Alzheimers Disease & Dementia

Gurmeet Kaur Surindar Singh, Mazzura Wan Chik and Nurul Aqmar Mohd Nor Hazalin

Universiti Teknologi MARA (UiTM)�Puncak Alam Campus, Malaysia Universiti Teknologi MARA (UiTM)�Shah Alam Campus, Malaysia

Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI:

Abstract
Alzheimerâ��s disease (AD) rat model can be reproduced via intrahippocampal (IH) administration of streptozotocin (STZ) in the ratâ��s brain. The hippocampus holds a large amount of insulin receptors (IRs) which are very sensitive to STZ. IRsâ�� exposure to STZ prompted memory impairment and production of amyloid-beta plaques related to AD pathogenesis. The present study is conducted to investigate the effects of IH-STZ administration on the progression of memory impairment and formation of amyloid �² (A�²) at 3, 6 and 12 weeks of STZ-treatment. Sixty male Sprague-Dawley rats (350â��450 g) were divided into groups of control (no treatment), sham-operated (received PBS) and IH-STZ treated (G3w, G6w and G12w). STZ (3 mg/ kg; 5 �µl) was administered bilaterally as a single injection into the dorsal hippocampus of the rats. The memory impairment was studied a week before decapitation using Morris water maze test. The rats were sacrificed at week 3, 6 and 12 after STZ administration and presence of A�² plaques were studied using the immunohistochemistry. All IH-STZ rats showed significant results in escape latency, total distance travelled and swimming speed (p<0.05) when compared to sham indicating memory impairment. In conclusion, STZ when injected intrahippocampally, developed memory impairment as early as two weeks after STZ treatment in the rats. gurmeet9952@puncakalam.uitm.edu.my
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top